Leriglitazon for X-ALD

About Neuraxpharm

Neuraxpharm is a well-established, privately-held European pharmaceutical company specializing in CNS disorders, operating in a high-need therapeutic area affecting one in three people globally. The company has evolved from a generic drug focus to a diversified CNS specialist with a portfolio spanning generics, branded established products, digital health devices, and partnerships for innovative therapies. Its strategy is built on geographic expansion across Europe, strategic acquisitions, and forging alliances to enhance its product offerings and address gaps in CNS care, positioning it for continued growth in a complex but critical market.

Therapeutic Areas

Other X-linked Adrenoleukodystrophy (X-ALD) Drugs